Rani Therapeutics Ownership | Who Owns Rani Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Rani Therapeutics Ownership Summary


Rani Therapeutics is owned by 19.79% institutional investors, 30.61% insiders, and 49.59% retail investors. Vanguard group is the largest institutional shareholder, holding 2.73% of RANI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.60% of its assets in Rani Therapeutics shares.

RANI Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRani Therapeutics19.79%30.61%49.59%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group709.83K2.73%$2.70M
Nan fung group493.58K1.90%$1.88M
Alphabet448.49K1.72%$1.70M
United services automobile association312.10K1.20%$1.19M
Geode capital management150.73K0.58%$572.92K
Stifel financial134.62K0.52%$511.56K
Bank of america corp /de/91.85K0.35%$349.01K
Bridgeway capital management71.50K0.27%$271.70K
Blackrock63.58K0.24%$241.62K
Lasry marc62.89K0.24%$238.97K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nan fung group493.58K2.00%$1.88M
Lasry marc62.89K0.24%$238.97K
Alphabet448.49K0.09%$1.70M
United services automobile association312.10K0.03%$1.19M
Islay capital management9.61K0.03%$36.52K
Lafayette investments19.89K0.02%$75.59K
Motco48.13K0.01%$182.89K
Bridgeway capital management71.50K0.01%$271.70K
Virtu financial10.15K0.00%$39.00K
King luther capital management56.13K0.00%$213.29K

Top Buyers

HolderShares% AssetsChange
Vanguard group709.83K0.00%24.52K
Bridgeway capital management71.50K0.01%20.00K
Geode capital management150.73K0.00%19.83K
Tower research capital llc (trc)14.44K0.00%13.20K
Virtu financial10.15K0.00%10.15K

Top Sellers

HolderShares% AssetsChange
United services automobile association312.10K0.03%-169.21K
Renaissance21.70K0.00%-48.60K
Alpha square group s---33.40K
Bank of america corp /de/91.85K--32.66K
Xr securities---30.90K

New Positions

HolderShares% AssetsChangeValue
Virtu financial10.15K0.00%10.15K$39.00K

Sold Out

HolderChange
Qube research-3.00
Wells fargo & company/mn-103.00
Belvedere trading-991.00
Activest wealth management-9.80K
Choreo-19.81K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202432-11.11%5,707,88197.28%1916.03%138.33%4-42.86%
Jun 30, 202436-2.70%2,893,303-7.12%117.45%12-740.00%
Mar 31, 20243715.63%3,115,1055.54%129.15%12140.00%5-16.67%
Dec 31, 202332-3.03%2,951,624-8.01%117.21%5-44.44%6-14.29%
Sep 30, 202333-8.33%3,208,534-0.58%127.74%9-43.75%7250.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv518.70K1.60%-
Vanguard Institutional Extnd Mkt Idx Tr172.98K0.53%-
Tema Obesity & Cardiometabolic ETF105.60K0.33%-
Fidelity Extended Market Index90.84K0.28%15.26K
Bridgeway Ultra-Small Company Market71.50K0.22%-
Northern Small Cap Core I23.70K0.08%23.70K
Fidelity Total Market Index26.25K0.08%-
Fidelity Series Total Market Index21.01K0.06%4.01K
BlackRock Extended Equity Market K16.40K0.06%-7.00
NT Ext Equity Mkt Idx Fd - L16.26K0.06%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 13, 2024McKinley Kate Chief Business OfficerBuy$29.99K
Dec 09, 2024Imran Talat Chief Executive OfficerBuy$19.97K
Oct 15, 2024South Cone Investments Limited Partnership-Sell$1.71M
Oct 15, 2024South Cone Investments Limited Partnership-Sell$8.44M
Nov 24, 2023Quiroga Cortes Isidoro Alfonso-Sell$10.58M

Insider Transactions Trends


DateBuySell
2024 Q412
2024 Q2--
2024 Q1--
2023 Q481
2023 Q3--

RANI Ownership FAQ


Who Owns Rani Therapeutics?

Rani Therapeutics shareholders are primarily institutional investors at 19.79%, followed by 30.61% insiders and 49.60% retail investors. The average institutional ownership in Rani Therapeutics's industry, Biotech Stocks , is 47.04%, which Rani Therapeutics falls below.

Who owns the most shares of Rani Therapeutics?

Rani Therapeutics’s largest shareholders are Vanguard group (709.83K shares, 2.73%), Nan fung group (493.58K shares, 1.90%), and Alphabet (448.49K shares, 1.72%). Together, they hold 6.35% of Rani Therapeutics’s total shares outstanding.

Does Blackrock own Rani Therapeutics?

Yes, BlackRock owns 0.24% of Rani Therapeutics, totaling 63.58K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 241.62K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Rani Therapeutics’s biggest shareholder by percentage of total assets invested?

Nan fung group is Rani Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.00% of its assets in 493.58K Rani Therapeutics shares, valued at 1.88M$.

Who is the top mutual fund holder of Rani Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Rani Therapeutics shares, with 1.60% of its total shares outstanding invested in 518.7K Rani Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools